Abstract
Orthopedic implant-related infection is a difficult clinical challenge, and a common cause of implant failure. Often due to bacterial biofilms formed on the implant surface, this unmet clinical need presents an opportunity for the development of new material technologies to make orthopedic implant surfaces less hospitable to bacterial colonization. Anti-infection material technologies are divided generally into three categories: passive surface modifications, active surface modifications, and perioperative local antibiotic carriers or coatings. Significant research has been published on technologies in each of these categories, and each approach offers potential advantages. Development of any anti-infection technology in orthopedics is made more difficult by the lack of good preclinical models of implant-related infection, a complex regulatory environment, a fragmented market, and indication-specific requirements for clinical data. Successful commercialization will depend on the identification of technical solutions to these nontechnical challenges.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bozic KJ, Kurtz SM, Lau E, et al. The epidemiology of revision total knee arthroplasty in the United States. Clin Orthop Relat Res. 2010;468(1):45–51.
Southwood RT, Rice JL, McDonald PJ, et al. Infection in experimental hip arthroplasties. J Bone Joint Surg Br. 1985;67(2):229–31.
Rezapoor M, Parvizi J. Prevention of periprosthetic joint infection. J Arthroplasty. 2015;30(6):902–7.
Voigt J, Mosier M, Darouiche R. Systematic review and meta-analysis of randomized controlled trials of antibiotics and antiseptics for preventing infection in people receiving primary total hip and knee prostheses. Antimicrob Agents Chemother. 2015;59(11):6696–707.
Stambough JB, Nam D, Warren DK, et al. Decreased hospital costs and surgical site infection incidence with a universal decolonization protocol in primary total joint arthroplasty. J Arthroplasty. 2017;32(3):728–34.
Gristina AG. Biomaterial-centered infection: microbial adhesion versus tissue integration. Science. 1987;237(4822):1588–95.
Busscher HJ, van der Mei HC, Subbiahdoss G, et al. Biomaterial-associated infection: locating the finish line in the race for the surface. Sci Transl Med. 2012;4(153):153rv10.
Zaborowska M, Tillander J, Brånemark R, et al. Biofilm formation and antimicrobial susceptibility of staphylococci and enterococci from osteomyelitis associated with percutaneous orthopaedic implants. J Biomed Mater Res B Appl Biomater. 2016. https://doi.org/10.1002/jbm.b.33803.
Arciola CR, Campoccia D, Speziale P, et al. Biofilm formation in Staphylococcus implant infections. A review of molecular mechanisms and implications for biofilm-resistant materials. Biomaterials. 2012;33(26):5967–82.
Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs. 2005;28(11):1062–8.
Archer NK, Mazaitis MJ, Costerton JW, et al. Staphylococcus aureus biofilms: properties, regulation, and roles in human disease. Virulence. 2011;2(5):445–59.
Stoodley P, Ehrlich GD, Sedghizadeh PP, et al. Orthopaedic biofilm infections. Curr Orthop Pract. 2011;22(6):558–63.
Torbert JT, Joshi M, Moraff A, et al. Current bacterial speciation and antibiotic resistance in deep infections after operative fixation of fractures. J Orthop Trauma. 2015;29(1):7–17.
Drago L, De Vecchi E, Bortolin M, et al. Epidemiology and antibiotic resistance of late prosthetic knee and hip infections. J Arthroplasty. 2017 Mar;32(8):2496–500.
Palmer MP, Altman DT, Altman GT, et al. Can we trust intraoperative culture results in nonunions? J Orthop Trauma. 2014;28(7):384–90.
Palmer M, Costerton JW, Sewecke J, et al. Molecular techniques to detect biofilm bacteria in long bone nonunion: a case report. Clin Orthop Relat Res. 2011;469(11):3037–42. https://doi.org/10.1007/s11999-011-1843-9.
Fraunholz M, Sinha B. Intracellular staphylococcus aureus: live-in and let die. Front Cell Infect Microbiol. 2012;2:43.
Broekhuizen CA, de Boer L, Schipper K, et al. Staphylococcus epidermidis is cleared from biomaterial implants but persists in peri-implant tissue in mice despite rifampicin/vancomycin treatment. J Biomed Mater Res A. 2008;85(2):498–505.
Sendi P, Proctor RA. Staphylococcus aureus as an intracellular pathogen: the role of small colony variants. Trends Microbiol. 2009;17(2):54–8. https://doi.org/10.1016/j.tim.2008.11.004.
de Mesy Bentley KL, Trombetta R, Nishitani K, et al. Evidence of staphylococcus aureus deformation, proliferation, and migration in canaliculi of live cortical bone in murine models of osteomyelitis. J Bone Miner Res. 2017;32(5):985–90.
BerrÃos-Torres SI, Umscheid CA, Bratzler DW, Healthcare Infection Control Practices Advisory Committee, et al. Centers for disease control and prevention guideline for the prevention of surgical site infection. JAMA Surg. 2017;152(8):784–91.
Hake ME, Young H, Hak DJ, et al. Local antibiotic therapy strategies in orthopaedic trauma: practical tips and tricks and review of the literature. Injury. 2015;46(8):1447–56.
Singh K, Bauer JM, LaChaud GY, et al. Surgical site infection in high-energy peri-articular tibia fractures with intra-wound vancomycin powder: a retrospective pilot study. J Orthop Traumatol. 2015;16(4):287–91.
Romanò CL, Scarponi S, Gallazzi E, et al. Antibacterial coating of implants in orthopaedics and trauma: a classification proposal in an evolving panorama. J Orthop Surg Res. 2015;10:157.
Willis-Owen CA, Konyves A, Martin DK. Factors affecting the incidence of infection in hip and knee replacement: an analysis of 5277 cases. J Bone Joint Surg Br. 2010;92(8):1128–33. https://doi.org/10.1302/0301-620X.92B8.24333.
Garrett TR, Bhakoo M, Zhang Z. Bacterial adhesion and biofilms on surfaces. Progress in Natural Science. 2008;18(9):1049–56.
Metsemakers WJ, Schmid T, Zeiter S, et al. Titanium and steel fracture fixation plates with different surface topographies: influence on infection rate in a rabbit fracture model. Injury. 2016;47(3):633–9.
Bagherifard S, Hickey DJ, de Luca AC, et al. The influence of nanostructured features on bacterial adhesion and bone cell functions on severely shot peened 316L stainless steel. Biomaterials. 2015;73:185–97.
Kummer KM, Taylor EN, Durmas NG, et al. Effects of different sterilization techniques and varying anodized TiO2 nanotube dimensions on bacteria growth. J Biomed Mater Res B Appl Biomater. 2013;101(5):677–88. https://doi.org/10.1002/jbm.b.32870. Epub 2013 Jan 29.
Bhardwaj G, Webster TJ. Reduced bacterial growth and increased osteoblast proliferation on titanium with a nanophase TiO2 surface treatment. Int J Nanomedicine. 2017;12:363–9.
Visai L, De Nardo L, Punta C, et al. Titanium oxide antibacterial surfaces in biomedical devices. Int J Artif Organs. 2011;34(9):929–46.
Fujishima A, Zhangb X, Tryk DA. TiO2 photocatalysis and related surface phenomena. Surf Sci Rep. 2008;63:515–82.
Foster HA, Ditta IB, Varghese S, et al. Photocatalytic disinfection using titanium dioxide: spectrum and mechanism of antimicrobial activity. Appl Microbiol Biotechnol. 2011;90(6):1847–68.
Roach MD, Williamson RS, Blakely IP, et al. Tuning anatase and rutile phase ratios and nanoscale surface features by anodization processing onto titanium substrate surfaces. Mater Sci Eng C Mater Biol Appl. 2016;58:213–23.
Lilja M, Welch K, Astrand M, et al. Effect of deposition parameters on the photocatalytic activity and bioactivity of TiO2 thin films deposited by vacuum arc on Ti-6Al-4V substrates. J Biomed Mater Res B Appl Biomater. 2012;100(4):1078–85.
Dunlop PS, Sheeran CP, Byrne JA, et al. Inactivation of clinically relevant pathogens by photocatalytic coatings. J Photochem Photobiol A. 2010;216(2):303–10.
Yue C, Kuijer R, Kaper HJ, et al. Simultaneous interaction of bacteria and tissue cells with photocatalytically activated, anodized titanium surfaces. Biomaterials. 2014;35(9):2580–7.
Jose B, Antoci V Jr, Zeiger AR, et al. Vancomycin covalently bonded to titanium beads kills Staphylococcus aureus. Chem Biol. 2005;12(9):1041-1048.
Antoci V Jr, Adams CS, Parvizi J, et al. The inhibition of Staphylococcus epidermidis biofilm formation by vancomycin-modified titanium alloy and implications for the treatment of periprosthetic infection. Biomaterials. 2008;29(35):4684–90.
Shapiro IM, Hickok NJ, Parvizi J, et al. Molecular engineering of an orthopaedic implant: from bench to bedside. Eur Cell Mater. 2012;23:362–70.
Antoci V Jr, Adams CS, Hickok NJ, et al. Vancomycin bound to Ti rods reduces periprosthetic infection: preliminary study. Clin Orthop Relat Res. 2007;461:88–95.
Stewart S, Barr S, Engiles J, et al. Vancomycin-modified implant surface inhibits biofilm formation and supports bone-healing in an infected osteotomy model in sheep: a proof-of-concept study. J Bone Joint Surg Am. 2012;94(15):1406–15.
Nie B, Ao H, Long T, et al. Immobilizing bacitracin on titanium for prophylaxis of infections and for improving osteoinductivity: An in vivo study. Colloids Surf B Biointerfaces. 2017;150:183–91.
Chen R, Willcox MD, Ho KK, et al. Antimicrobial peptide melimine coating for titanium and its in vivo antibacterial activity in rodent subcutaneous infection models. Biomaterials. 2016;85:142–51.
Godoy-Gallardo M, Mas-Moruno C, Fernández-Calderón MC, et al. Covalent immobilization of hLf1-11 peptide on a titanium surface reduces bacterial adhesion and biofilm formation. Acta Biomater. 2014;10(8):3522–34.
Schaer TP, Stewart S, Hsu BB, et al. Hydrophobic polycationic coatings that inhibit biofilms and support bone healing during infection. Biomaterials. 2012;33(5):1245–54. https://doi.org/10.1016/j.biomaterials.2011.10.038.
Levin PD. The effectiveness of various antibiotics in methyl methacrylate. J Bone Joint Surg Br. 1975;57(2):234–7.
Buchholz HW, Elson RA, Engelbrecht E, et al. Management of deep infection of total hip replacement. J Bone Joint Surg Br. 1981;63-B(3):342–53.
Cui Q, Mihalko WM, Shields JS, et al. Antibiotic-impregnated cement spacers for the treatment of infection associated with total hip or knee arthroplasty. J Bone Joint Surg Am. 2007;89(4):871–82.
Bertazzoni Minelli E, Benini A, et al. Antimicrobial activity of gentamicin and vancomycin combination in joint fluids after antibiotic-loaded cement spacer implantation in two-stage revision surgery. J Chemother. 2015;27(1):17–24. https://doi.org/10.1179/1973947813Y.0000000157.
Conway J, Mansour J, Kotze K, et al. Antibiotic cement-coated rods: an effective treatment for infected long bones and prosthetic joint nonunions. Bone Joint J. 2014;96-B(10):1349–54.
Thonse R, Conway J. Antibiotic cement-coated interlocking nail for the treatment of infected nonunions and segmental bone defects. J Orthop Trauma. 2007;21(4):258–68.
Ohtsuka H, Yokoyama K, Higashi K, et al. Use of antibiotic-impregnated bone cement nail to treat septic nonunion after open tibial fracture. J Trauma. 2002;52(2):364–6.
Eckman JB Jr, Henry SL, Mangino PD, et al. Wound and serum levels of tobramycin with the prophylactic use of tobramycin-impregnated polymethylmethacrylate beads in compound fractures. Clin Orthop Relat Res. 1988;237:213–5.
Lewis G. Properties of antibiotic-loaded acrylic bone cements for use in cemented arthroplasties: a state-of-the-art review. J Biomed Mater Res B Appl Biomater. 2009;89(2):558–74.
Meyer J, Piller G, Spiegel CA, et al. Vacuum-mixing significantly changes antibiotic elution characteristics of commercially available antibiotic-impregnated bone cements. J Bone Joint Surg Am. 2011;93(22):2049–56.
Chang Y, Tai CL, Hsieh PH, et al. Gentamicin in bone cement: a potentially more effective prophylactic measure of infectionin joint arthroplasty. Bone Joint Res. 2013;2(10):220–6.
Neut D, van de Belt H, Stokroos I, et al. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother. 2001;47(6):885–91.
Anagnostakos K, Hitzler P, Pape D, et al. Persistence of bacterial growth on antibiotic-loaded beads: is it actually a problem? Acta Orthop. 2008;79(2):302–7. https://doi.org/10.1080/17453670710015120.
Mäkinen TJ, Veiranto M, Knuuti J, et al. Efficacy of bioabsorbable antibiotic containing bone screw in the prevention of biomaterial-related infection due to Staphylococcus aureus. Bone. 2005;36(2):292–9.
Price JS, Tencer AF, Arm DM, et al. Controlled release of antibiotics from coated orthopedic implants. J Biomed Mater Res. 1996;30(3):281–6.
Gollwitzer H, Ibrahim K, Meyer H, et al. Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery technology. J Antimicrob Chemother. 2003;51(3):585–91.
Kälicke T, Schierholz J, Schlegel U, et al. Effect on infection resistance of a local antiseptic and antibiotic coating on osteosynthesis implants: an in vitro and in vivo study. J Orthop Res. 2006;24(8):1622–40.
Lucke M, Schmidmaier G, Sadoni S, et al. Gentamicin coating of metallic implants reduces implant-related osteomyelitis in rats. Bone. 2003;32(5):521–31.
Nast S, Fassbender M, Bormann N, et al. In vivo quantification of gentamicin released from an implant coating. J Biomater Appl. 2016;31(1):45–54.
Vester H, Wildemann B, Schmidmaier G, et al. Gentamycin delivered from a PDLLA coating of metallic implants: In vivo and in vitro characterisation for local prophylaxis of implant-related osteomyelitis. Injury. 2010;41(10):1053–9.
Fuchs T, Stange R, Schmidmaier G, et al. The use of gentamicin-coated nails in the tibia: preliminary results of a prospective study. Arch Orthop Trauma Surg. 2011;131(10):1419–25.
Metsemakers WJ, Reul M, Nijs S. The use of gentamicin-coated nails in complex open tibia fracture and revision cases: a retrospective analysis of a single centre case series and review of the literature. Injury. 2015;46(12):2433–7.
Neut D, Dijkstra RJ, Thompson JI, et al. A biodegradable gentamicin-hydroxyapatite-coating for infection prophylaxis in cementless hip prostheses. Eur Cell Mater. 2015;29:42–55.
Metsemakers WJ, Emanuel N, Cohen O, et al. A doxycycline-loaded polymer-lipid encapsulation matrix coating for the prevention of implant-related osteomyelitis due to doxycycline-resistant methicillin-resistant Staphylococcus aureus. J Control Release. 2015;209:47–56.
Radin S, Ducheyne P, Kamplain T, et al. Silica sol-gel for the controlled release of antibiotics. I. Synthesis, characterization, and in vitro release. J Biomed Mater Res. 2001;57(2):313–20.
Qu H, Knabe C, Radin S, et al. Percutaneous external fixator pins with bactericidal micron-thin sol-gel films for the prevention of pin tract infection. Biomaterials. 2015;62:95–105.
FDA. Draft guidance for industry and FDA staff: premarket notification [510(k)] submissions for medical devices that include antimicrobial agents 2007. https://www.fda.gov/downloads/medicaldevices/deviceregulationandguidance/guidancedocuments/ucm071396.pdf. Accessed 29 May 2017.
FDA. Guidance for industry and FDA staff: current good manufacturing practice requirements for combination products. 2015. https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm429304.pdf. Accessed 29 May 2017.
Cai X, Han K, Cong X, et al. The use of calcium sulfate impregnated with vancomycin in the treatment of open fractures of long bones: a preliminary study. Orthopedics. 2010;33(3). https://doi.org/10.3928/01477447-20100129-17.
Emanuel N, Rosenfeld Y, Cohen O, et al. A lipid-and-polymer-based novel local drug delivery system-BonyPid™: from physicochemical aspects to therapy of bacterially infected bones. J Control Release. 2012;160(2):353–61. https://doi.org/10.1016/j.jconrel.2012.03.027.
Alexander JW. History of the medical use of silver. Surg Infect (Larchmt). 2009;10(3):289–92.
Lai NM, Chaiyakunapruk N, Lai NA, et al. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults. Cochrane Database of Syst Rev. 2013; (6): CD007878.
Lam TB, Omar MI, Fisher E, et al. Types of indwelling urethral catheters for short-term catheterisation in hospitalised adults. Cochrane Database Syst Rev. 2014; (9):CD004013.
Karchmer TB, Giannetta ET, Muto CA, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med. 2000;160(21):3294–8.
Feng QL, Wu J, Chen GQ, et al. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. J Biomed Mater Res. 2000;52(4):662–8.
Lansdown AB. A pharmacological and toxicological profile of silver as an antimicrobial agent in medical devices. Adv Pharmacol Sci. 2010;2010:910686.
Mulley G, Jenkins AT, Waterfield NR. Inactivation of the antibacterial and cytotoxic properties of silver ions by biologically relevant compounds. PLoS One. 2014;9(4):e94409.
Lansdown AB. Silver in healthcare: its antimicrobial efficacy and safety in use. Cambridge: RSC Publishing; 2010. https://doi.org/10.1039/9781849731799.
Massè A, Bruno A, Bosetti M, et al. Prevention of pin track infection in external fixation with silver coated pins: clinical and microbiological results. J Biomed Mater Res. 2000;53(5):600–4.
Wassall MA, Santin M, Isalberti C, et al. Adhesion of bacteria to stainless steel and silver-coated orthopedic external fixation pins. J Biomed Mater Res. 1997;36(3):325–30.
Collinge CA, Goll G, Seligson D, et al. Pin tract infections: silver vs uncoated pins. Orthopedics. 1994;17(5):445–8.
Coester LM, Nepola JV, Allen J, et al. The effects of silver coated external fixation pins. Iowa Orthop J. 2006;26:48–53.
Schmidt-Braekling T, Streitbuerger A, Gosheger G, et al. Silver-coated megaprostheses: review of the literature. Eur J Orthop Surg Traumatol. 2017;27(4):483–9.
Donati F, Di Giacomo G, D'Adamio S, et al. Silver-coated hip megaprosthesis in oncological limb savage surgery. Biomed Res Int. 2016;2016:9079041.
Piccioli A, Donati F, Giacomo GD, et al. Infective complications in tumour endoprostheses implanted after pathological fracture of the limbs. Injury. 2016;47(Suppl 4):S22–8.
Hussmann B, Johann I, Kauther MD, et al. Measurement of the silver ion concentration in wound fluids after implantation of silver-coated megaprostheses: correlation with the clinical outcome. Biomed Res Int. 2013;2013:763096.
Hardes J, von Eiff C, Streitbuerger A, et al. Reduction of periprosthetic infection with silver-coated megaprostheses in patients with bone sarcoma. J Surg Oncol. 2010;101(5):389–95.
Glehr M, Leithner A, Friesenbichler J, et al. Argyria following the use of silver-coated megaprostheses: no association between the development of local argyria and elevated silver levels. Bone Joint J. 2013;95-B(7):988–92.
Hardes J, Ahrens H, Gebert C, et al. Lack of toxicological side-effects in silver-coated megaprostheses in humans. Biomaterials. 2007;28(18):2869–75.
Wafa H, Grimer RJ, Reddy K, et al. Retrospective evaluation of the incidence of early periprosthetic infection with silver-treated endoprostheses in high-risk patients: case-control study. Bone Joint J. 2015;97-B(2):252–7.
Scoccianti G, Frenos F, Beltrami G, et al. Levels of silver ions in body fluids and clinical results in silver-coated megaprostheses after tumour, trauma or failed arthroplasty. Injury. 2016;47(Suppl 4):S11–6.
Hauschild G, Hardes J, Gosheger G, et al. Evaluation of osseous integration of PVD-silver-coated hip prostheses in a canine model. Biomed Res Int. 2015;2015:292406.
Khalilpour P, Lampe K, Wagener M, et al. Ag/SiO(x)C(y) plasma polymer coating for antimicrobial protection of fracture fixation devices. J Biomed Mater Res B Appl Biomater. 2010;94(1):196–202.
Zielinska E, Tukaj C, Radomski MW, et al. Molecular mechanism of silver nanoparticles-induced human osteoblast cell death: protective effect of inducible nitric oxide synthase inhibitor. PLoS One. 2016;11(10):e0164137.
Rosário F, Hoet P, Santos C, et al. Death and cell cycle progression are differently conditioned by the AgNP size in osteoblast-like cells. Toxicology. 2016;368-369:103–15.
Esfandiari N, Simchi A, Bagheri R. Size tuning of Ag-decorated TiO2 nanotube arrays for improved bactericidal capacity of orthopedic implants. J Biomed Mater Res A. 2014;102(8):2625–35.
Zhao Y, Xing Q, Janjanam J, et al. Facile electrochemical synthesis of antimicrobial TiO2 nanotube arrays. Int J Nanomedicine. 2014;9:5177–87.
Pauksch L, Hartmann S, Rohnke M, et al. Biocompatibility of silver nanoparticles and silver ions in primary human mesenchymal stem cells and osteoblasts. Acta Biomater. 2014;10(1):439–49.
Sengstock C, Diendorf J, Epple M, et al. Effect of silver nanoparticles on human mesenchymal stem cell differentiation. Beilstein J Nanotechnol. 2014;5:2058–69.
Necula BS, van Leeuwen JP, Fratila-Apachitei LE, et al. In vitro cytotoxicity evaluation of porous TiO2-Ag antibacterial coatings for human fetal osteoblasts. Acta Biomater. 2012;8(11):4191–7.
Greulich C, Kittler S, Epple M, et al. Studies on the biocompatibility and the interaction of silver nanoparticles with human mesenchymal stem cells (hMSCs). Langenbecks Arch Surg. 2009;394(3):495–502.
Ning C, Wang X, Li L, et al. Concentration ranges of antibacterial cations for showing the highest antibacterial efficacy but the least cytotoxicity against mammalian cells: implications for a new antibacterial mechanism. Chem Res Toxicol. 2015;28(9):1815–22.
Kraft CN, Hansis M, Arens S, et al. Striated muscle microvascular response to silver implants: a comparative in vivo study with titanium and stainless steel. J Biomed Mater Res. 2000;49(2):192–9.
Welz C Osteointegrative eigenschaften einer silberbeschichtung von hüftendoprothesen bei hunden. Dissertation. Westfälische Wilhelms Universität Münster; 2008.
Kabata T, Maeda T, Kajino Y, et al. Iodine-supported hip implants: short term clinical results. Biomed Res Int. 2015;2015:368124.
Demura S, Murakami H, Shirai T, et al. Surgical treatment for pyogenic vertebral osteomyelitis using iodine-supported spinal instruments: initial case series of 14 patients. Eur J Clin Microbiol Infect Dis. 2015;34(2):261–6.
Shirai T, Tsuchiya H, Nishida H, et al. Antimicrobial megaprostheses supported with iodine. J Biomater Appl. 2014;29(4):617–23.
Tsuchiya H, Shirai T, Nishida H, et al. Innovative antimicrobial coating of titanium implants with iodine. J Orthop Sci. 2012;17(5):595–604.
Tennent DJ, Shiels SM, Sanchez CJ Jr, et al. Time-dependent effectiveness of locally applied vancomycin powder in a contaminated traumatic orthopaedic wound model. J Orthop Trauma. 2016;30(10):531–7.
Armaghani SJ, Menge TJ, Lovejoy SA, et al. Safety of topical vancomycin for pediatric spinal deformity: nontoxic serum levels with supratherapeutic drain levels. Spine (Phila Pa 1976). 2014;39(20):1683–7.
Khan NR, Thompson CJ, DeCuypere M, et al. A meta-analysis of spinal surgical site infection and vancomycin powder. J Neurosurg Spine. 2014;21(6):974–83.
Kang DG, Holekamp TF, Wagner SC, et al. Intrasite vancomycin powder for the prevention of surgical site infection in spine surgery: a systematic literature review. Spine J. 2015;15(4):762–70.
Chiang HY, Herwaldt LA, Blevins AE, et al. Effectiveness of local vancomycin powder to decrease surgical site infections: a meta-analysis. Spine J. 2014;14(3):397–407.
Tubaki VR, Rajasekaran S, Shetty AP. Effects of using intravenous antibiotic only versus local intrawound vancomycin antibiotic powder application in addition to intravenous antibiotics on postoperative infection in spine surgery in 907 patients. Spine (Phila Pa 1976). 2013;38(25):2149–55.
Whiteside LA, Roy ME. One-stage revision with catheter infusion of intraarticular antibiotics successfully treats infected THA. Clin Orthop Relat Res. 2017;475(2):419–29.
Lawing CR, Lin FC, Dahners LE. Local injection of aminoglycosides for prophylaxis against infection in open fractures. J Bone Joint Surg Am. 2015;97(22):1844–51.
Giavaresi G, Meani E, Sartori M, et al. Efficacy of antibacterial-loaded coating in an in vivo model of acutely highly contaminated implant. Int Orthop. 2014;38(7):1505–12.
Malizos K, Blauth M, Danita A, et al. Fast-resorbable antibiotic-loaded hydrogel coating to reduce post-surgical infection after internal osteosynthesis: a multicenter randomized controlled trial. J Orthop Traumatol. 2017;18(2):159–69.
Penn-Barwell JG, Murray CK, Wenke JC. Local antibiotic delivery by a bioabsorbable gel is superior to PMMA bead depot in reducing infection in an open fracture model. J Orthop Trauma. 2014;28(6):370–5.
Bennett-Guerrero E, Berry SM, Bergese SD, et al. A randomized, blinded, multicenter trial of a gentamicin vancomycin gel (DFA-02) in patients undergoing abdominal surgery. Am J Surg. 2017;213(6):1003–9.
Jennings JA, Carpenter DP, Troxel KS, et al. Novel antibiotic-loaded point-of-care implant coating inhibits biofilm. Clin Orthop Relat Res. 2015;473(7):2270–82.
Jennings JA, Beenken KE, Skinner RA, et al. Antibiotic-loaded phosphatidylcholine inhibits staphylococcal bone infection. World J Orthop. 2016;7(8):467–74.
Hesse W. Walther, Angelina Hesse-Early Contributors to Bacteriology. ASM News. 1992;58(8):425–8.
Kinnari TJ, Peltonen LI, Kuusela P, et al. Bacterial adherence to titanium surface coated with human serum albumin. Otol Neurotol. 2005;26(3):380–4.
Incani V, Omar A, Prosperi-Porta G, et al. Ag5IO6: novel antibiofilm activity of a silver compound with application to medical devices. Int J Antimicrob Agents. 2015;45(6):586–93.
ASTM International. Standard test method for testing disinfectant efficacy against Pseudomonas aeruginosa biofilm using the MBEC assay. E2799-11. West Conshohocken, PA; 2011.
Melcher GA, Claudi B, Schlegel U, et al. Influence of type of medullary nail on the development of local infection. An experimental study of solid and slotted nails in rabbits. J Bone Joint Surg Br. 1994;76(6):955–9.
Lambe DW Jr, Ferguson KP, Mayberry-Carson KJ, et al. Foreign-body-associated experimental osteomyelitis induced with Bacteroides fragilis and Staphylococcus epidermidis in rabbits. Clin Orthop Relat Res. 1991;266:285–94.
Williams DL, Haymond BS, Woodbury KL, et al. Experimental model of biofilm implant-related osteomyelitis to test combination biomaterials using biofilms as initial inocula. J Biomed Mater Res A. 2012;100(7):1888–900.
Williams DL, Costerton JW. Using biofilms as initial inocula in animal models of biofilm-related infections. J Biomed Mater Res B Appl Biomater. 2012;100(4):1163–9.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Armbruster, D. (2018). Anti-Infection Technologies for Orthopedic Implants: Materials and Considerations for Commercial Development. In: Li, B., Webster, T. (eds) Orthopedic Biomaterials . Springer, Cham. https://doi.org/10.1007/978-3-319-89542-0_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-89542-0_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89541-3
Online ISBN: 978-3-319-89542-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)